These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis. Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564 [TBL] [Abstract][Full Text] [Related]
6. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433 [TBL] [Abstract][Full Text] [Related]
7. Porous Se@SiO Yang BY; Deng GY; Zhao RZ; Dai CY; Jiang CY; Wang XJ; Jing YF; Liu XJ; Xia SJ; Han BM Acta Biomater; 2019 Apr; 88():392-405. PubMed ID: 30753941 [TBL] [Abstract][Full Text] [Related]
9. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention. Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134 [TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in prostate hyperplasia and carcinogenesis. Udensi UK; Tchounwou PB J Exp Clin Cancer Res; 2016 Sep; 35(1):139. PubMed ID: 27609145 [TBL] [Abstract][Full Text] [Related]
11. Iodine prevents the increase of testosterone-induced oxidative stress in a model of rat prostatic hyperplasia. Quintero-García M; Delgado-González E; Sánchez-Tusie A; Vázquez M; Aceves C; Anguiano B Free Radic Biol Med; 2018 Feb; 115():298-308. PubMed ID: 29248723 [TBL] [Abstract][Full Text] [Related]
12. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis. Nickel JC Curr Opin Urol; 2006 Jan; 16(1):5-10. PubMed ID: 16385194 [TBL] [Abstract][Full Text] [Related]
13. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095 [TBL] [Abstract][Full Text] [Related]
14. Prostatic Lesions in Odontocete Cetaceans. Suárez-Santana CM; Sierra E; Díaz-Delgado J; Zucca D; de Quirós YB; Puig-Lozano R; Câmara N; De la Fuente J; de Los Monteros AE; Rivero M; Arbelo M; Fernández A Vet Pathol; 2018 May; 55(3):466-472. PubMed ID: 29402205 [TBL] [Abstract][Full Text] [Related]
15. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats. Wu X; Gu Y; Li L Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977 [TBL] [Abstract][Full Text] [Related]
16. Dying for love: Perimenopausal degeneration of vaginal microbiome drives the chronic inflammation-malignant transformation of benign prostatic hyperplasia to prostatic adenocarcinoma. Reece AS Med Hypotheses; 2017 Apr; 101():44-47. PubMed ID: 28351489 [TBL] [Abstract][Full Text] [Related]
17. Testosterone and Benign Prostatic Hyperplasia. Rastrelli G; Vignozzi L; Corona G; Maggi M Sex Med Rev; 2019 Apr; 7(2):259-271. PubMed ID: 30803920 [TBL] [Abstract][Full Text] [Related]
18. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia. Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617 [TBL] [Abstract][Full Text] [Related]
19. Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer. Irani J; Millet C; Levillain P; Doré B; Begon F; Aubert J Eur Urol; 1996; 29(4):407-12. PubMed ID: 8791046 [TBL] [Abstract][Full Text] [Related]
20. Benign and malignant prostatic diseases. Crawford ED Am Fam Physician; 1991 Nov; 44(5 Suppl):65S-70S. PubMed ID: 1950983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]